Table 2 Breathing for Life Trial Study Procedures
Visit 1 (Control group) | Visit 1 (FENO group) | Follow-up Visits (FENO group) | |
|---|---|---|---|
Time frame | 12–22+6 weeks gestation | 12–22+6 weeks gestation | Every 3–6 weeks |
Consent | ✓ | ✓ | |
Inclusion/exclusion | ✓ | ✓ | |
Other illnesses | ✓ | ✓ | |
Asthma diagnosis | ✓ | ✓ | |
Randomisation | ✓ | ✓ | |
Demographics | ✓ | ✓ | |
Height & weight | ✓ | ✓ | |
Smoking questions | ✓ | ✓ | ✓ |
Ethnicity | ✓ | ✓ | |
Occupation | ✓ | ✓ | |
FENO | ✓ | ✓ | |
Spirometry | ✓ | ✓ | ✓ |
ECO | ✓ | ✓ | ✓ |
ACQ | ✓ | ✓ | |
Asthma history | ✓ | ✓ | |
Current medications | ✓ | ✓ | ✓ |
Current symptoms | ✓ | ✓ | ✓ |
Self-management education | ✓ | ✓ | ✓ |
Written action plan | ✓ | ||
FENO treatment algorithm | ✓ | ✓ (every 2nd visit) | |
Medication supply | ✓ | ✓ | |
Written information provided | ✓ | ✓ | |
Letter to GP/primary carer | ✓ | ✓ |